what are the Recommendations for Use of Biomarkers for Prevention, Initial Diagno-
sis, and Risk Stratification
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In patients presenting with dyspnea, measure- ment of B-type natriuretic peptide (BNP) or N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) is useful to support a diagnosis or exclusion of HF.